29.08.2022
Four 20 Pharma expands its product portfolio with the product line "420 EVOLUTION" and the indica-dominant cultivar "Ice Cream Cake Kush Mints".
Paderborn, 29.08.2022 - Four 20 Pharma GmbH is expanding its range of medicinal cannabis flowers with the cultivar "Ice Cream Cake Kush Mints", or ICC for short. Patients will have access to the new strain starting in September.
ICC kicks off the new "EVOLUTION" product line from Four 20 Pharma GmbH. The category stands for the most exclusive flowers in high quality, as well as high THC content.The indica-dominant hybrid comes from the crossing of two top genetics, both of which promise a high medical benefit for themselves and through their combination was further potentiated. In addition, the cultivar impresses with a rich terpene profile and convinces with a particularly pleasant taste.
The unirradiated flowers are produced in Canada in strict compliance with GMP requirements, where they are gently dried, hand-processed and hand-trimmed before the pharmaceutical drug is manufactured by trained personnel of Four 20 Pharma GmbH in Paderborn.
Four 20 Pharma GmbH plans to add further cultivars to this "420 EVOLUTION" product line in the coming months.
About Four 20 Pharma
Four 20 Pharma GmbH is a specialist in the field of medical cannabis and offers high-quality products made from the dried flower of the cannabis plant. The focus of our day-to-day activities is to provide the best possible medical care for patients. With our diverse range of medical cannabis, we contribute to providing patients with optimal treatment. Our claim is to consistently maintain the highest pharmaceutical quality standards. Therefore, we make sure that our suppliers and partners are GDP and GMP certified without exception. Because of our philosophy, patients, physicians, pharmacies and medical facilities can rely on consistent quality & availability of our medical cannabis products.
